“…In previous studies, it has been stated that clinical parameters such as antiarrhythmic medication, valvular disease, statin, beta-blocker, and angiotensin converting enzyme/angiotensin receptor blocker (ACE/ARB) use before cardioversion, LA dilatation, pulmonary disease, cardiomyopathy, HT, body weight, duration of AF, and OSAS can be indicative for the success of cardioversion [7][8][9][10][11][12][13][14][15][16][17][18]. However, in this study only COPD, CHF, OSAS, valvular disease, HATCH score, LA diameter, EF, and age remained as independent predictors of unsuccessful EC.…”